Veradigm | MDRX - Operating Expenses


Veradigm reported $188M in Operating Expenses for its fiscal quarter ending in December of 2022.





Operating Expenses Change Date
Alcidion AUD 23.27M 565K Dec/2025
Ambu A/S DKK 1.4B 6M Mar/2026
Amplifon EUR 526.12M 613K Jun/2026
Cardinal Health USD -2.83B 52M Mar/2026
Centene USD 22.56B 1.14B Jun/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cigna USD 42.62B 410M Jun/2026
Coloplast 5.19B 185M Dec/2025
Convatec Group USD 1B 518M Dec/2024
CVS Health USD 95.75B 7.84B Mar/2026
Diasorin EUR 231M 511K Mar/2026
Elevance Health USD 44.88B 981M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Gulf Medical Proj AED 182.97M 16.46M Dec/2025
Humana USD 39.51B 1.61B Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Laboratory Of America USD 3.27B 146.9M Jun/2026
Maximus USD 1.7B 22.85M Mar/2026
McKesson USD 94.46B 10.04B Mar/2026
Med Life RON 809.23M 61.36M Mar/2026
Molina Healthcare USD 10.72B 6.64B Jun/2026
Omnicell USD 275.89M 16.96M Jun/2026
Oriola-kd EUR 45.4M 451.2M Mar/2026
Owens Minor USD -464.76M 1.17B Mar/2026
Quest Diagnostics USD 2.58B 88M Jun/2026
Rede D'or Sao Luiz BRL 11.43B 385.31M Mar/2026
Siemens Healthineers EUR 4.82B 137M Jun/2026
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 167.61M 83.39M Mar/2026
UnitedHealth USD 104.04B 1.36B Jun/2026
Veeva Systems USD 609.84M 19.76M Mar/2026
Veradigm USD 188M 61.08M Dec/2022
Xerox USD 299M 145M Mar/2026